These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 11249531

  • 1. Butenafine hydrochloride: for the treatment of interdigital tinea pedis.
    Syed TA, Maibach HI.
    Expert Opin Pharmacother; 2000 Mar; 1(3):467-73. PubMed ID: 11249531
    [Abstract] [Full Text] [Related]

  • 2. Effects of butenafine hydrochloride, a new benzylamine derivative, on experimental tinea pedis in guinea pigs.
    Arika T, Yokoo M, Maeda T, Amemiya K, Yamaguchi H.
    Antimicrob Agents Chemother; 1990 Nov; 34(11):2254-5. PubMed ID: 2073117
    [Abstract] [Full Text] [Related]

  • 3. Butenafine and superficial mycoses: current status.
    Singal A.
    Expert Opin Drug Metab Toxicol; 2008 Jul; 4(7):999-1005. PubMed ID: 18624686
    [Abstract] [Full Text] [Related]

  • 4. Treatment of interdigital tinea pedis with a 4-week once-daily regimen of butenafine hydrochloride 1% cream.
    Tschen E, Elewski B, Gorsulowsky DC, Pariser DM.
    J Am Acad Dermatol; 1997 Feb; 36(2 Pt 1):S9-14. PubMed ID: 9039199
    [Abstract] [Full Text] [Related]

  • 5. One-week therapy with twice-daily butenafine 1% cream versus vehicle in the treatment of tinea pedis: a multicenter, double-blind trial.
    Savin R, De Villez RL, Elewski B, Hong S, Jones T, Lowe N, Lucky A, Reyes B, Stewart D, Willis I.
    J Am Acad Dermatol; 1997 Feb; 36(2 Pt 1):S15-9. PubMed ID: 9039200
    [Abstract] [Full Text] [Related]

  • 6. Butenafine.
    McNeely W, Spencer CM.
    Drugs; 1998 Mar; 55(3):405-12; discussion 413. PubMed ID: 9530545
    [Abstract] [Full Text] [Related]

  • 7. Effects of butenafine hydrochloride, a new benzylamine derivative, on experimental dermatophytosis in guinea pigs.
    Arika T, Yokoo M, Hase T, Maeda T, Amemiya K, Yamaguchi H.
    Antimicrob Agents Chemother; 1990 Nov; 34(11):2250-3. PubMed ID: 2073116
    [Abstract] [Full Text] [Related]

  • 8. Topical butenafine for tinea pedis.
    Med Lett Drugs Ther; 1997 Jul 04; 39(1004):63-4. PubMed ID: 9217695
    [No Abstract] [Full Text] [Related]

  • 9. Topical treatment with butenafine significantly lowers relapse rate in an interdigital tinea pedis model in guinea pigs.
    Arika T, Yokoo M, Yamaguchi H.
    Antimicrob Agents Chemother; 1992 Nov 04; 36(11):2523-5. PubMed ID: 1489197
    [Abstract] [Full Text] [Related]

  • 10. Butenafine: an update of its use in superficial mycoses.
    Gupta AK.
    Skin Therapy Lett; 2002 Sep 04; 7(7):1-2, 5. PubMed ID: 12432425
    [Abstract] [Full Text] [Related]

  • 11. Efficacy and safety of butenafine in superficial dermatophytoses (tinea pedis, tinea cruris, tinea corporis).
    Saple DG, Amar AK, Ravichandran G, Korde KM, Desai A.
    J Indian Med Assoc; 2001 May 04; 99(5):274-5. PubMed ID: 11676116
    [Abstract] [Full Text] [Related]

  • 12. Anti-Trichophyton mentagrophytes activity and percutaneous permeation of butenafine in guinea pigs.
    Arika T, Hase T, Yokoo M.
    Antimicrob Agents Chemother; 1993 Feb 04; 37(2):363-5. PubMed ID: 8452371
    [Abstract] [Full Text] [Related]

  • 13. Butenafine hydrochloride (Mentax) cream for the treatment of hyperkeratotic type tinea pedis and its transfer into the horny layer, with or without concomitant application of 20% urea ointment (Keratinamin).
    Tanuma H, Doi M, Ohta Y, Abe M, Kume H, Mukai H, Katsuoka K.
    Mycoses; 2001 Feb 04; 44(7-8):287-99. PubMed ID: 11714064
    [Abstract] [Full Text] [Related]

  • 14. Terbinafine. An update of its use in superficial mycoses.
    McClellan KJ, Wiseman LR, Markham A.
    Drugs; 1999 Jul 04; 58(1):179-202. PubMed ID: 10439936
    [Abstract] [Full Text] [Related]

  • 15. [Treatment of interdigital tinea pedis].
    Korting HC, Rychlik R, Pfeil B.
    Dtsch Med Wochenschr; 2003 Sep 05; 128(36):1819-24. PubMed ID: 12964099
    [Abstract] [Full Text] [Related]

  • 16. Fungicidal activity plus reservoir effect allow short treatment courses with terbinafine in tinea pedis.
    Schäfer-Korting M, Schoellmann C, Korting HC.
    Skin Pharmacol Physiol; 2008 Sep 05; 21(4):203-10. PubMed ID: 18509254
    [Abstract] [Full Text] [Related]

  • 17. Naftifine Hydrochloride Gel 2%: An Effective Topical Treatment for Moccasin-Type Tinea Pedis.
    Stein Gold LF, Vlahovic T, Verma A, Olayinka B, Fleischer AB.
    J Drugs Dermatol; 2015 Oct 05; 14(10):1138-44. PubMed ID: 26461826
    [Abstract] [Full Text] [Related]

  • 18. Butenafine 1% cream in the treatment of tinea cruris: a multicenter, vehicle-controlled, double-blind trial.
    Lesher JL, Babel DE, Stewart DM, Jones TM, Kaminester L, Goldman M, Weintraub JS.
    J Am Acad Dermatol; 1997 Feb 05; 36(2 Pt 1):S20-4. PubMed ID: 9039201
    [Abstract] [Full Text] [Related]

  • 19. Optimizing topical antifungal therapy for superficial cutaneous fungal infections: focus on topical naftifine for cutaneous dermatophytosis.
    Del Rosso JQ, Kircik LH.
    J Drugs Dermatol; 2013 Nov 05; 12(11 Suppl):s165-71. PubMed ID: 24196340
    [Abstract] [Full Text] [Related]

  • 20. Butenafine, a fungicidal benzylamine derivative, used once daily for the treatment of interdigital tinea pedis.
    Reyes BA, Beutner KR, Cullen SI, Rosen T, Shupack JL, Weinstein MB.
    Int J Dermatol; 1998 Jun 05; 37(6):450-3. PubMed ID: 9646136
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.